Buffalo Regenerative Medicine: A 2026 Safety & Credential Checklist
Introduction: Why Buffalo Patients Need a Safety Checklist, Not Just a Clinic List
A search for “regenerative medicine Buffalo” in 2026 returns a long list of clinic landing pages. Most promote PRP, stem cell, and exosome injections with confident language about healing, repair, and renewal. Very few disclose a product’s FDA status or explain the physician’s actual credentials.
That gap creates a real problem. Patients dealing with joint pain, osteoarthritis, or a sports injury often cannot tell an evidence-based orthobiologic treatment apart from an unproven and potentially risky product. On a website, both can sound equally scientific.
This article offers a neutral, evidence-based checklist. It draws on New York State’s own verification tools, including the NYSED Office of the Professions, the New York Physician Profile, and the Office of Professional Medical Conduct, along with current FDA and FTC regulatory facts. Readers will learn how to:
- Check a provider’s license and disciplinary history
- Read FDA approval status for PRP, stem cells, and exosomes
- Distinguish true board certification (ABMS) from a knowledge-only credential (ABRM)
TopDoctor Magazine presents this guide as an educational layer. It is not a directory and not a single clinic’s marketing page. Its purpose is to help readers ask the right questions before booking a consultation.
What “Regenerative Medicine” Actually Means in Buffalo Right Now
“Regenerative medicine” is an umbrella term. It covers legitimate academic research, FDA-regulated biologics, and loosely regulated commercial clinic offerings. All three often use the same marketing vocabulary.
Buffalo has a genuine research presence in this field. The University at Buffalo established its Stem Cells in Regenerative Medicine (SCiRM) training program in fall 2016 with funding from the New York Stem Cell Board. UB also hosts the Cell, Gene and Tissue Engineering (CGTE) Center, where researchers in chemical, biological, and biomedical engineering work on stem cell engineering, tissue regeneration, and translational science.
That academic work is fundamentally different from commercial “stem cell therapy” injections sold directly to consumers for joint pain, anti-aging, or chronic disease. Research programs operate under institutional oversight and peer review. Direct-to-consumer clinics frequently do not.
The local market also shows how far the label stretches. Several Buffalo-area practices advertise stem cell and PRP injections alongside cosmetic services such as Botox and HydraFacials. When orthopedic biologics and aesthetic treatments share one brand, the average patient has little way to judge which offerings rest on solid evidence. The sections below separate marketing claims from regulatory and clinical reality.
The FDA Approval Status Checklist: PRP vs. Stem Cells vs. Exosomes
FDA status is the single most important fact many patients do not know before signing a consent form. The three most commonly marketed categories sit in very different regulatory positions.
PRP (Platelet-Rich Plasma): Off-Label but Evidence-Backed
PRP is not FDA-approved as a drug. It is, however, legally offered off-label. The treatment uses a patient’s own blood, which is processed with FDA-cleared devices to concentrate platelets before injection.
The evidence base is substantial and growing. A 2025 narrative review in the Journal of Clinical Medicine synthesized 40 high-quality studies and found that leukocyte-poor PRP delivered superior pain relief and functional improvement compared with hyaluronic acid and corticosteroids in mild-to-moderate knee osteoarthritis.
Formulation matters. PRP can be leukocyte-rich (containing more white blood cells) or leukocyte-poor. Because the strongest osteoarthritis data favour leukocyte-poor preparations, patients should ask any Buffalo provider which type they use and why. Among the three categories discussed here, PRP currently has the strongest evidence.
Stem Cells: Only One FDA-Approved Use Exists, and It Is Not Orthopedic
The only FDA-approved stem cell products in the United States are hematopoietic (blood-forming) stem cells derived from umbilical cord blood. They are approved exclusively for disorders affecting blood production.
Any clinic offering “stem cell therapy” for joints, neurologic conditions, or anti-aging is therefore using an unapproved product or using a product outside its approved indication.
The risks are documented. The CDC has investigated bloodstream infection outbreaks, including a multi-state outbreak and product recall, linked to contaminated unapproved umbilical-cord-derived injections marketed as stem cell therapy.
The legal landscape has also shifted decisively. In September 2024, the Ninth Circuit Court of Appeals unanimously ruled that a clinic’s stromal vascular fraction (SVF) procedure, which processes a patient’s own fat tissue, is a “drug” under the Food, Drug, and Cosmetic Act. The court held it did not qualify for the “same surgical procedure” exception. In October 2025, the U.S. Supreme Court declined to hear an appeal, leaving the FDA’s regulatory authority over these therapies firmly in place.
Plain-language takeaway: If a Buffalo clinic offers same-day, fat-derived “stem cell” injections, patients should ask directly how that procedure fits within current FDA enforcement.
Exosomes: The Least Regulated, Least Studied Category
Exosome products have no FDA approval for any therapeutic indication. Independent reviewers have found very little high-quality randomized evidence that exosomes work for any orthopedic condition.
Exosome marketing often borrows credibility from stem cell and PRP research, despite resting on a much thinner evidence base. Patients should treat exosome offerings as experimental and ask specifically about:
- Where the product is sourced
- Whether the manufacturer is FDA-registered
- Whether the treatment is part of a registered clinical trial
Understanding the Credentialing Gap: ABRM vs. ABMS
The American Board of Medical Specialties (ABMS) is the largest and most widely recognized physician-led certification organization in the United States. It covers more than 150 specialties and subspecialties and certifies over 80% of practicing U.S. physicians. ABMS certification requires completion of accredited residency training and rigorous specialty examinations.
The American Board of Regenerative Medicine (ABRM) is a credential many clinics cite. By its own disclosure, ABRM is not affiliated with or a member of ABMS. ABRM also states that its certification evaluates knowledge competency only and does not evaluate clinical competency or define a physician’s scope of practice in regenerative medicine.
A practical question helps here: patients can ask any Buffalo provider, “Which board certifies your primary specialty?” For joint and musculoskeletal conditions, relevant ABMS-recognized fields include orthopedic surgery, physical medicine and rehabilitation, and sports medicine. A “regenerative medicine board certified” claim should be viewed as supplementary, never as a substitute for ABMS credentials.
A credential-sounding name on a wall or website is not verification. It is a prompt for follow-up questions.
New York’s Free Verification Tools: How to Check Any Buffalo Provider in Minutes
This is the practical core of the checklist. Every tool below is official, free, and usable immediately.
NYSED Office of the Professions License Search
The New York State Education Department’s Office of the Professions maintains the official database for confirming whether a physician is currently licensed to practice in New York. Patients should check:
- License status: active, expired, or revoked
- Registration dates: whether current registration is up to date
- Licensed profession: what the person is actually licensed to practice
The same search covers other licensed professionals who may be involved in care, such as physician assistants and nurse practitioners who administer injections.
The New York Physician Profile
The New York Physician Profile provides public information on NY-licensed physicians, including education, training, hospital affiliations, board certifications, and disclosures of malpractice and criminal history.
For regenerative medicine, this tool is especially useful. It lets patients confirm whether a provider’s actual training, such as orthopedics, sports medicine, or PM&R, matches what a clinic website advertises. Profiles may also flag malpractice judgments or criminal convictions relevant to a safety decision.
Office of Professional Medical Conduct (OPMC)
OPMC investigates physician misconduct complaints and issues disciplinary actions in New York State. Before scheduling a consultation, patients should search OPMC records for formal actions, consent orders, or practice restrictions tied to the provider. This serves as the final due-diligence step after confirming license status and credentials.
Beyond the FDA and Credentials: Enforcement Actions Patients Should Know About
Federal oversight extends beyond the FDA. In 2024 and 2025, the Federal Trade Commission obtained permanent bans and monetary relief against regenerative medicine promoters who falsely claimed stem cells could treat Parkinson’s disease, autism, and macular degeneration.
Combined with the Ninth Circuit ruling and the Supreme Court’s refusal to revisit it, these actions show that regulators are increasing scrutiny, not relaxing it.
This matters locally. Aggressive claims seen on some Buffalo clinic pages echo language that has drawn federal enforcement elsewhere. Patients should be cautious when a single injection is promoted for a long list of unrelated conditions.
The FDA also maintains a consumer adverse-event reporting system for unapproved regenerative products. It allows patients to report problems, and FDA safety communications can help readers understand prior concerns about specific product types.
The Buffalo Regenerative Medicine Red Flag List
This side-by-side list works as a quick reference before and after researching a specific provider.
Red flags:
- No disclosure of a product’s FDA status
- Vague claims that one treatment works for many unrelated conditions
- Pressure to pay upfront in cash for “stem cell” packages
- No mention of cell sourcing or lab processing standards
- Inability to confirm ABMS board certification in a relevant specialty
- Refusal to discuss IRB oversight for investigational products
Green flags:
- ABMS-certified in a specialty relevant to the condition
- Transparent about off-label PRP use, with cited evidence
- Willing to discuss FDA-registered lab and product sourcing
- Clean NYSED license record and no OPMC actions
A Step-by-Step Verification Checklist Before Your Buffalo Consultation
- Identify the exact product or procedure being offered and ask directly about its FDA approval status.
- Look up the physician in the NYSED Office of the Professions license search.
- Review the NY Physician Profile for training, affiliations, and disciplinary history.
- Check OPMC for formal actions, consent orders, or restrictions.
- Confirm board certification is ABMS-recognized and relevant to the condition being treated.
- Ask about product sourcing, lab processing standards, and whether an investigational treatment is part of a registered clinical trial.
Patients are encouraged to bring these steps as literal questions into an initial consultation rather than relying on website claims. The full process takes under 30 minutes and uses only free, official tools.
Where TopDoctor Magazine Fits Into This Decision
TopDoctor Magazine is not a directory or booking platform, and this article does not rank or endorse specific Buffalo clinics. The publication’s role is to serve as an educational layer, translating FDA, credentialing, and New York State regulatory information into plain language so patients can evaluate any provider independently.
This coverage reflects the magazine’s broader editorial focus on regenerative, functional, integrative, and personalized medicine. Its contributor network includes VP of Research Joseph Krieger, founder and president of Boston Biolife, whose work centers on regenerative and personalized medicine.
TopDoctor’s nomination and awards process also adds a layer of distinction. Nominations must come from someone other than the nominee, such as a peer, a patient, or a magazine representative, and nominees must provide positive patient testimonials and sit for an interview. That process separates editorially recognized providers from purely self-promoted marketing. Readers can use this checklist alongside TopDoctor’s physician profiles and interviews as part of their own research.
Conclusion: Informed Patients Make Safer Choices
Regenerative medicine spans a wide spectrum. At one end sits well-studied, legally offered PRP. Further along are unapproved stem cell products, and beyond them, largely unproven exosome treatments. The terminology alone will not tell a patient which category is being offered.
Three pillars of due diligence close that gap:
- Regulatory status: what the FDA and FTC have approved, restricted, or acted against
- Credential verification: ABMS certification versus knowledge-only credentials like ABRM
- State lookup tools: NYSED, the NY Physician Profile, and OPMC
Given active federal enforcement and documented safety incidents, spending 30 minutes verifying a Buffalo provider is a reasonable and increasingly necessary step. Verification is not distrust. It is empowerment, and patients who complete this homework can pursue regenerative treatment with far greater confidence.
Next Step: Research Before You Book
Before scheduling a consultation, readers should run a prospective Buffalo provider’s name through the NYSED Office of the Professions search and the New York Physician Profile.
For additional context on regenerative and orthopedic medicine, TopDoctor Magazine’s physician interviews and specialty coverage offer a deeper look at how experienced practitioners approach these treatments. Readers who want ongoing consumer-focused healthcare education, including updates on regulatory changes affecting regenerative medicine, can subscribe to the free TopDoctor Magazine newsletter.
Finally, readers who know a Buffalo-area physician who meets this article’s credentialing and transparency standards can recommend that provider through TopDoctor Magazine’s nomination platform.
